Ertaczo found effective in more than just fighting infection

WAIKOLOA, Hawaii According to new research, the antifungal foot medication Ertaczo, by OrthoNeutrogena, a division of Ortho-McNeil Pharmaceuticals, has also been found effective in treating the inflammation and itching associated with the disorder.

According to a presentation given by Leon Kircik, associate clinical professor of dermatology at Indiana University, “Not only is sertaconazole (Ertaczo) highly effective in eradicating the infection of tinea pedis (fungal foot infection), but its action against inflammation and itching may further contribute to successful outcomes.”

Tinea pedis affects about 70 percent of Americans at some point in their lives.